{
  "id": "clinical#management_a24bbbdf",
  "content": "Disorders due to substance use or addictive behaviours | Substance classes\nDisorders due to substance use or addictive behaviours 447\n6C4B Disorders due to use of volatile inhalants\nDisorders due to use of volatile inhalants are characterized by the pattern and consequences of\nvolatile inhalant use. Volatile inhalants include a range of compounds that are in the gaseous or\nvapour phase at ambient temperatures, such as various organic solvents, glues, gasoline (petrol),\nnitrites and gases such as nitrous oxide, trichloroethane, butane, toluene, fluorocarbons, ether\nand halothane. They have a range of pharmacological properties but are predominantly central\nnervous system depressants, with many also having vasoactive effects. They tend to be used by\nyounger people, and may be used when access to alternative psychoactive substances is difficult or\nimpossible. Volatile inhalant intoxication is well recognized. Volatile inhalants have dependence-\nproducing properties, and volatile inhalant dependence and volatile inhalant withdrawal\nare recognized, although comparatively uncommon worldwide. Volatile inhalant-induced\nmental disorders are described. Volatile inhalants may also cause neurocognitive impairment,\nincluding dementia.\n6C4C Disorders due to use of MDMA or related drugs, including MDA\nDisorders due to use of 3,4-Methyle nedioxy methamfetamine (MDMA) or related drugs, including",
  "metadata": {
    "source": "WHO ICD-11",
    "url": "https://icd.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "management"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General â€” Management Disorders due to substance use or addictive behaviours | Substance classes\nDisorders due to substance use or addictive behaviours 447\n6C4B Disorders due to use of volatile inhalants\nDisorders due to use of volatile inhalants are characterized by the pattern and consequences of\nvolatile inhalant use. Volatile inhalants include a range of compounds that are in the gaseous or\nvapour phase at ambient temperatures, such as various organic solvents, glues, gasoline (petrol),\nnitrites and gases such as nitrous oxide, trichloroethane, butane, toluene, fluorocarbons, ether\nand halothane. They have a range of pharmacological properties but are predominantly central\nnervous system depressants, with many also having vasoactive effects. They tend to be used by\nyounger people, and may be used when access to alternative psychoactive substances is difficult or\nimpossible. Volatile inhalant intoxication is well recognized. Volatile inhalants have dependence-\nproducing properties, and volatile inhalant dependence and volatile inhalant withdrawal\nare recognized, although comparatively uncommon worldwide. Volatile inhalant-induced\nmental disorders are described. Volatile inhalants may also cause neurocognitive impairment,\nincluding dementia.\n6C4C Disorders due to use of MDMA or related drugs, including MDA\nDisorders due to use of 3,4-Methyle nedioxy methamfetamine (MDMA) or related drugs, including Disorders due to substance use or addictive behaviours | substance classes\ndisorders due to substance use or addictive behaviours 447\n6c4b disorders due to use of volatile inhalants\ndisorders due to use of volatile inhal..."
}